* Illumina Inc reported quarterly adjusted earnings of 9 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of 8 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from -11 cents to 25 cents per share.
* Revenue fell 1% to $1.08 billion from a year ago; analysts expected $1.05 billion.
* Illumina Inc's reported EPS for the quarter was a loss of 79 cents.
* The company reported a quarterly loss of $126 million.
* Illumina Inc shares had fallen by 9.7% this quarter and lost 11.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 36.7% in the last three months.
* In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy," 12 "hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Illumina Inc is $145.00 This summary was machine generated from LSEG data May 3 at 01:36 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.04 0.09 Beat
Dec. 31 2023 0.02 0.14 Beat
Sep. 30 2023 0.12 0.33 Beat
Jun. 30 2023 0.02 0.32 Beat
Comments